ABSTRACT
In recent years public awareness of healthcare disparities experienced by transgender individuals throughout the world have garnered increasing attention within the media and from health advocates. Despite this increasing awareness, a paucity of research data and clinical protocols of care for clinicians continues to exist, especially in regard to the transgender individual's family planning needs. Clinicians should be on the forefront of promoting strategies that forge a meaningful and collaborative relationship with the transgender man, including as he transitions through to the menopause and his sexual and reproductive healthcare needs. Unfortunately, despite best efforts to address the health concerns of transgender men in midlife, including their contraceptive needs and pregnancy desires, there is currently a paucity of research. Although hormonal contraceptives are not an option for this group of individuals, especially those on masculinizing hormones, IUD's, both copper containing and progestin containing, should be considered for those with intact pelvic organs. For this group of transgender men with potential for pregnancy who have either completed their family or choose not to give birth, sterilization can be offered. Regardless of where they identify along the gender spectrum, these midlife individuals with potential reproductive potential should have equitable access to and up to date counseling on their contraceptive options. This commentary addresses the contraceptive challenges of the midlife transgender man. (Note: Pronouns used in this article are he/him for cis and transgender men and she/her for cis and transgender women).
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Cat Diseases/chemically induced , Drug Hypersensitivity/veterinary , Fenbendazole/adverse effects , Vasculitis/veterinary , Animals , Antineoplastic Agents, Alkylating/therapeutic use , Cat Diseases/pathology , Cats , Chlorambucil/therapeutic use , Drug Hypersensitivity/complications , Drug Hypersensitivity/pathology , Ear, External/pathology , Female , Foot/pathology , Hematocrit/veterinary , Immunosuppressive Agents/therapeutic use , Pentoxifylline/therapeutic use , Prednisolone/therapeutic use , Tail/pathology , Vasculitis/chemically induced , Vasculitis/pathology , Vasodilator Agents/therapeutic useABSTRACT
Ileocolic intussusception was successfully treated surgically by partial enterectomy and enteroplication in an 11-month-old, male neutered German shepherd dog. Segmental intestinal volvulus was identified in the same dog two months later and was managed successfully by a second partial enterectomy. The dog made an uneventful recovery and was free of clinical disease six months after the second surgery. Both conditions are reviewed in this case report and a possible relationship between these two episodes in this dog is discussed.
